Fulgent Genetics, Inc. Financial Ratios
FLGT / Health Care|FY2025 SEC 10-K data
Includes DuPont ROE decomposition, profitability margins, liquidity ratios, solvency indicators, and earnings quality analysis. All ratios calculated from FY2025 SEC 10-K data.
Key Data Points
- Altman Z-Score 5.28 (safe zone, above 2.9 threshold)
- Negative profit margin: -15.1%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
DuPont ROE Decomposition (FY2025)
Return on Equity
-5.4%
Profit Margin
-18.8%
Net Income / Revenue
Asset Turnover
0.27
Revenue / Total Assets
Equity Multiplier
1.09
Total Assets / Equity
Composite: -5.4% (reported: -5.4%)
Profitability
Liquidity
Current Ratio
6.48
Quick Ratio
6.48
Solvency
Interest Coverage
-
Efficiency
Asset Turnover
0.27
Inventory Turnover
-
Days Sales Outstanding
96 days
As of FY2025 · SEC 10-K · Updated Jun 30, 2026
Earnings Quality
Accrual Ratio
+3.4%
+8.6pp YoY
Earnings include a notable portion of accrual components.
This metric is for informational purposes only and does not constitute investment advice. Data sourced from SEC EDGAR filings; updates may be delayed.